drugset / Trial / NCT00435799
Evaluating Collagen Cross-Linking (CCL) Treatment in Norway
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess safety, efficacy and stability of riboflavin-UV induced cross-linking of corneal collagen in reducing the progression of keratecatasia and in improving visual acuity. This is the first Norwegian study concerning CCL.
Timeline
- Start
- 2007-02
- Primary completion
- 2009-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Riboflavin | Other / unclassified | — | Topical |